Cancer despite immunosurveillance: immunoselection and immunosubversion

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• The immune system, through cancer immunosurveillance, identifies and eliminates cancerous cells using innate and adaptive immune components.
• Cancer cells develop mechanisms like immunoselection (outgrowth of less immunogenic variants) and immunosuppression (subversion of immune responses) to evade this surveillance.
• Early carcinogenesis involves cell-intrinsic barriers and active anti-tumor immunity, contrasting with overt tumor development linked to altered tumor cell immunogenicity.

Purpose of the Study:

• To explore the interplay between cancer cells and the immune system, focusing on mechanisms of immune evasion.
• To understand the role of tumor immunogenicity in different stages of cancer development.
• To investigate the potential of immunogenic chemotherapy in overcoming cancer immune evasion and enhancing treatment efficacy.

Main Methods:

• The study reviews existing literature on cancer immunosurveillance, immunoselection, and immunosuppression.
• Analysis of the relationship between tumor cell immunogenicity and cancer progression.
• Conceptual framework for the role of immunogenic chemotherapy in re-establishing anti-tumor immune responses.

Main Results:

• Cancer cells actively evade immune detection through specific evolutionary and subversive strategies.
• Tumor immunogenicity is a critical factor influencing the success or failure of immunosurveillance and tumor progression.
• Immunogenic chemotherapy shows promise in restoring anti-tumor immunity, potentially leading to more durable cancer treatment outcomes.

Conclusions:

• Effective cancer treatment may necessitate strategies that not only target tumor cells directly but also re-engage the host immune system.
• Harnessing immunogenic chemotherapy could be a vital approach to overcome cancer immune evasion and achieve lasting therapeutic success.